Quipt Home Medical Corp. (QIPT) Financial Ratios
27 years of historical data (1999–2025) · Healthcare · Medical - Devices
EV/EBITDA
↓
6.37
+4% vs avg
5yr avg: 6.16
30Y Low1.8·High11.3
P/FCF
↓
6.34
↓-19% vs avg
5yr avg: 7.85
30Y Low1.1·High31.3
P/B Ratio
↓
1.41
↓-24% vs avg
5yr avg: 1.84
30Y Low0.1·High3.7
ROE
↑
-9.8%
↑-87% vs avg
5yr avg: -5.2%
30Y Low-234%·High33%
Debt/EBITDA
↑
2.84
↑+49% vs avg
5yr avg: 1.90
30Y Low0.1·High42.1
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
QIPT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Quipt Home Medical Corp. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 6.3x P/FCF, 19% below the 5-year average of 7.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $161M | $113M | $124M | $202M | $155M | $192M | $89M | $54M | $11M | $22M | $11M |
| Enterprise Value | $267M | $120M | $208M | $283M | $178M | $185M | $88M | $66M | $24M | $32M | $16M |
| P/E Ratio → | -14.60 | — | — | — | 32.08 | — | — | — | 0.75 | — | — |
| P/S Ratio | 0.66 | 0.46 | 0.50 | 0.96 | 1.11 | 1.88 | 1.22 | 0.88 | 0.20 | 0.36 | 0.11 |
| P/B Ratio | 1.41 | 1.01 | 1.16 | 1.82 | 1.95 | 3.28 | 3.15 | 3.74 | 0.73 | 0.31 | 0.12 |
| P/FCF | 6.34 | 4.46 | 4.95 | 6.72 | 9.03 | 14.07 | 9.07 | 7.69 | 1.08 | — | — |
| P/OCF | 4.26 | 3.00 | 3.51 | 5.47 | 5.89 | 10.28 | 9.00 | 6.44 | 1.02 | — | — |
P/E links to full P/E history page with 30-year chart
QIPT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Quipt Home Medical Corp.'s enterprise value stands at 6.4x EBITDA, roughly in line with its 5-year average of 6.2x. The Healthcare sector median is 14.4x, placing the stock at a 56% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.49 | 0.84 | 1.34 | 1.27 | 1.80 | 1.20 | 1.07 | 0.44 | 0.52 | 0.17 |
| EV / EBITDA | 6.37 | 2.87 | 4.02 | 6.17 | 6.42 | 11.30 | 6.30 | 11.08 | 3.75 | — | — |
| EV / EBIT | — | — | 404.15 | 57.48 | 35.55 | — | — | — | — | — | — |
| EV / FCF | — | 4.74 | 8.29 | 9.40 | 10.37 | 13.52 | 8.91 | 9.34 | 2.36 | — | — |
QIPT Profitability
Margins and return-on-capital ratios measuring operating efficiency
Quipt Home Medical Corp. earns an operating margin of -1.6%. Operating margins have compressed from 2.7% to -1.6% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -9.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 97.5% | 97.5% | 72.0% | 72.6% | 76.3% | 72.5% | 52.5% | 72.1% | 69.2% | 70.9% | 50.9% |
| Operating Margin | -1.6% | -1.6% | 0.5% | 2.7% | 3.4% | -1.4% | -0.9% | -7.6% | -9.7% | -20.9% | -42.2% |
| Net Profit Margin | -4.4% | -4.4% | -2.8% | -1.3% | 3.5% | -6.0% | -6.2% | -9.1% | 26.6% | -31.1% | -59.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -9.8% | -9.8% | -6.2% | -2.9% | 7.0% | -14.2% | -21.4% | -38.0% | 33.5% | -23.5% | -51.7% |
| ROA | -3.9% | -3.9% | -2.7% | -1.5% | 4.0% | -6.8% | -8.0% | -14.0% | 20.6% | -17.9% | -42.4% |
| ROIC | -1.4% | -1.4% | 0.4% | 3.0% | 4.8% | -2.8% | -1.8% | -12.9% | -7.2% | -10.8% | -30.7% |
| ROCE | -1.8% | -1.8% | 0.6% | 4.2% | 5.7% | -2.4% | -1.8% | -19.5% | -9.5% | -13.9% | -35.4% |
QIPT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Quipt Home Medical Corp. carries a Debt/EBITDA ratio of 2.8x, which is moderately leveraged (14% below the sector average of 3.3x). Net debt stands at $7M ($119M total debt minus $13M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.06 | 1.06 | 0.93 | 0.88 | 0.33 | 0.46 | 0.98 | 1.47 | 1.09 | 0.18 | 0.12 |
| Debt / EBITDA | 2.84 | 2.84 | 1.93 | 2.13 | 0.96 | 1.66 | 2.00 | 3.60 | 2.56 | — | — |
| Net Debt / Equity | — | 0.06 | 0.78 | 0.73 | 0.29 | -0.13 | -0.05 | 0.80 | 0.87 | 0.14 | 0.06 |
| Net Debt / EBITDA | 0.17 | 0.17 | 1.62 | 1.76 | 0.83 | -0.46 | -0.11 | 1.96 | 2.04 | — | — |
| Debt / FCF | — | 0.28 | 3.34 | 2.68 | 1.34 | -0.55 | -0.15 | 1.65 | 1.28 | — | — |
| Interest Coverage | -0.57 | -0.57 | 0.12 | 0.76 | 2.46 | -0.73 | -0.34 | -1.42 | -3.60 | -11.42 | -36.00 |
QIPT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.05x means Quipt Home Medical Corp. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.71x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.05 | 1.05 | 1.20 | 1.08 | 1.00 | 1.75 | 1.86 | 1.29 | 1.25 | 1.30 | 2.10 |
| Quick Ratio | 0.71 | 0.71 | 0.86 | 0.78 | 0.62 | 1.47 | 1.59 | 1.09 | 0.94 | 0.74 | 1.68 |
| Cash Ratio | 0.17 | 0.17 | 0.27 | 0.28 | 0.20 | 1.06 | 1.20 | 0.54 | 0.24 | 0.19 | 0.35 |
| Asset Turnover | — | 0.80 | 1.00 | 0.86 | 1.06 | 0.94 | 1.02 | 1.47 | 1.44 | 0.60 | 0.86 |
| Inventory Turnover | 0.24 | 0.24 | 3.31 | 3.14 | 2.13 | 3.04 | 5.41 | 4.77 | 4.98 | 2.27 | 3.91 |
| Days Sales Outstanding | — | 51.62 | 43.22 | 44.79 | 42.76 | 42.57 | 45.34 | 55.84 | 64.82 | 45.50 | 69.42 |
QIPT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Quipt Home Medical Corp. returns 0.1% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 3.1% | — | — | — | 133.3% | — | — |
| FCF Yield | 15.8% | 22.4% | 20.2% | 14.9% | 11.1% | 7.1% | 11.0% | 13.0% | 92.8% | — | — |
| Buyback Yield | 0.1% | 0.1% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.1% | 0.1% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $43M | $43M | $40M | $37M | $30M | $23M | $21M | $20M | $19M | $18M |
Peer Comparison
Compare QIPT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 QIPTYou | $161M | -14.6 | 6.4 | 6.3 | 97.5% | -1.6% | -9.8% | -1.4% | 2.8 |
 HCSG | $2B | 27.5 | 22.4 | 11.5 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 |
 EHAB | $706M | -152.1 | 13.5 | 10.7 | 46.9% | 6.0% | -0.8% | 4.5% | 5.8 |
 NKTR | $2B | -8.6 | — | — | 100.0% | -236.8% | -217.9% | -57.2% | — |
 INVA | $2B | 6.9 | 8.1 | 9.9 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 LINC | $1B | 67.8 | 31.7 | — | — | 5.8% | 10.6% | 6.8% | 4.1 |
 SUPN | $3B | -76.9 | 53.4 | 65.5 | 89.6% | -5.1% | -3.7% | -2.8% | 0.7 |
 PHG | $26B | 24.9 | 10.7 | 24.7 | 45.2% | 8.0% | 7.8% | 6.4% | 3.2 |
 AVNS | $1B | -17.0 | — | 26.9 | 49.8% | -8.8% | -8.5% | -5.4% | — |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 MASI | $9B | -63.8 | 27.7 | 47.3 | 61.9% | 20.5% | -17.1% | 16.5% | 1.6 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 27 years · Updated daily
See QIPT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs QIPT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare QIPT vs HCSG
Side-by-side business, growth, and profitability comparison vs Healthcare Services Group, Inc..
Start ComparisonQIPT — Frequently Asked Questions
Quick answers to the most common questions about buying QIPT stock.
What is Quipt Home Medical Corp.'s P/E ratio?
Quipt Home Medical Corp.'s current P/E ratio is -14.6x. The historical average is 16.4x.
What is Quipt Home Medical Corp.'s EV/EBITDA?
Quipt Home Medical Corp.'s current EV/EBITDA is 6.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 6.0x.
What is Quipt Home Medical Corp.'s ROE?
Quipt Home Medical Corp.'s return on equity (ROE) is -9.8%. The historical average is -62.2%.
Is QIPT stock overvalued?
Based on historical data, Quipt Home Medical Corp. is trading at a P/E of -14.6x. Compare with industry peers and growth rates for a complete picture.
What are Quipt Home Medical Corp.'s profit margins?
Quipt Home Medical Corp. has 97.5% gross margin and -1.6% operating margin.
How much debt does Quipt Home Medical Corp. have?
Quipt Home Medical Corp.'s Debt/EBITDA ratio is 2.8x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.